Role of surgical treatment for esthesioneuroblastomas: 31-Year experience at a single institution

Chi Sang Hwang, Young Wook Seo, Sang Chul Park, Hyo Jin Chung, Hyung Ju Cho, Joo Heon Yoon, Chang-Hoon Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective This study aimed to re-assess the outcomes of different surgical methods for esthesioneuroblastoma (ENB) in a single institution, with emphasis on changes in surgical treatment with regard to endoscopic approaches in patients with ENB. Subjects and methods We retrospectively reviewed the data of 35 patients with ENB treated over the last 31 years. Results The 5-year overall and disease-free survival rates were 66.8% and 50.8%, respectively. Disease-free survival in the endoscopic surgery group was significantly higher compared to that of craniofacial surgery group (P = 0.035). In the endoscopic surgery group, nine of 10 patients did not exhibit local failure or regional recurrence over a mean followup period of 64.3 months, which was longer than the mean time to recurrence (22.0 months) observed in this study. Conclusion Given its significant survival outcomes and high rate of local control, endoscopic surgery could be preferred as a minimally invasive treatment with potentially low morbidity and possible oncological validity for the treatment of ENB.

Original languageEnglish
Pages (from-to)120-126
Number of pages7
JournalJournal of Cranio-Maxillofacial Surgery
Volume45
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Olfactory Esthesioneuroblastoma
Disease-Free Survival
Recurrence
Therapeutics
Survival Rate
Morbidity
Survival

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology

Cite this

Hwang, Chi Sang ; Seo, Young Wook ; Park, Sang Chul ; Chung, Hyo Jin ; Cho, Hyung Ju ; Yoon, Joo Heon ; Kim, Chang-Hoon. / Role of surgical treatment for esthesioneuroblastomas : 31-Year experience at a single institution. In: Journal of Cranio-Maxillofacial Surgery. 2017 ; Vol. 45, No. 1. pp. 120-126.
@article{b1a13b772b3a4db6b098ee74a15c5afc,
title = "Role of surgical treatment for esthesioneuroblastomas: 31-Year experience at a single institution",
abstract = "Objective This study aimed to re-assess the outcomes of different surgical methods for esthesioneuroblastoma (ENB) in a single institution, with emphasis on changes in surgical treatment with regard to endoscopic approaches in patients with ENB. Subjects and methods We retrospectively reviewed the data of 35 patients with ENB treated over the last 31 years. Results The 5-year overall and disease-free survival rates were 66.8{\%} and 50.8{\%}, respectively. Disease-free survival in the endoscopic surgery group was significantly higher compared to that of craniofacial surgery group (P = 0.035). In the endoscopic surgery group, nine of 10 patients did not exhibit local failure or regional recurrence over a mean followup period of 64.3 months, which was longer than the mean time to recurrence (22.0 months) observed in this study. Conclusion Given its significant survival outcomes and high rate of local control, endoscopic surgery could be preferred as a minimally invasive treatment with potentially low morbidity and possible oncological validity for the treatment of ENB.",
author = "Hwang, {Chi Sang} and Seo, {Young Wook} and Park, {Sang Chul} and Chung, {Hyo Jin} and Cho, {Hyung Ju} and Yoon, {Joo Heon} and Chang-Hoon Kim",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.jcms.2016.10.004",
language = "English",
volume = "45",
pages = "120--126",
journal = "Journal of Cranio-Maxillo-Facial Surgery",
issn = "1010-5182",
publisher = "Churchill Livingstone",
number = "1",

}

Role of surgical treatment for esthesioneuroblastomas : 31-Year experience at a single institution. / Hwang, Chi Sang; Seo, Young Wook; Park, Sang Chul; Chung, Hyo Jin; Cho, Hyung Ju; Yoon, Joo Heon; Kim, Chang-Hoon.

In: Journal of Cranio-Maxillofacial Surgery, Vol. 45, No. 1, 01.01.2017, p. 120-126.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of surgical treatment for esthesioneuroblastomas

T2 - 31-Year experience at a single institution

AU - Hwang, Chi Sang

AU - Seo, Young Wook

AU - Park, Sang Chul

AU - Chung, Hyo Jin

AU - Cho, Hyung Ju

AU - Yoon, Joo Heon

AU - Kim, Chang-Hoon

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective This study aimed to re-assess the outcomes of different surgical methods for esthesioneuroblastoma (ENB) in a single institution, with emphasis on changes in surgical treatment with regard to endoscopic approaches in patients with ENB. Subjects and methods We retrospectively reviewed the data of 35 patients with ENB treated over the last 31 years. Results The 5-year overall and disease-free survival rates were 66.8% and 50.8%, respectively. Disease-free survival in the endoscopic surgery group was significantly higher compared to that of craniofacial surgery group (P = 0.035). In the endoscopic surgery group, nine of 10 patients did not exhibit local failure or regional recurrence over a mean followup period of 64.3 months, which was longer than the mean time to recurrence (22.0 months) observed in this study. Conclusion Given its significant survival outcomes and high rate of local control, endoscopic surgery could be preferred as a minimally invasive treatment with potentially low morbidity and possible oncological validity for the treatment of ENB.

AB - Objective This study aimed to re-assess the outcomes of different surgical methods for esthesioneuroblastoma (ENB) in a single institution, with emphasis on changes in surgical treatment with regard to endoscopic approaches in patients with ENB. Subjects and methods We retrospectively reviewed the data of 35 patients with ENB treated over the last 31 years. Results The 5-year overall and disease-free survival rates were 66.8% and 50.8%, respectively. Disease-free survival in the endoscopic surgery group was significantly higher compared to that of craniofacial surgery group (P = 0.035). In the endoscopic surgery group, nine of 10 patients did not exhibit local failure or regional recurrence over a mean followup period of 64.3 months, which was longer than the mean time to recurrence (22.0 months) observed in this study. Conclusion Given its significant survival outcomes and high rate of local control, endoscopic surgery could be preferred as a minimally invasive treatment with potentially low morbidity and possible oncological validity for the treatment of ENB.

UR - http://www.scopus.com/inward/record.url?scp=85006319378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006319378&partnerID=8YFLogxK

U2 - 10.1016/j.jcms.2016.10.004

DO - 10.1016/j.jcms.2016.10.004

M3 - Article

C2 - 27840119

AN - SCOPUS:85006319378

VL - 45

SP - 120

EP - 126

JO - Journal of Cranio-Maxillo-Facial Surgery

JF - Journal of Cranio-Maxillo-Facial Surgery

SN - 1010-5182

IS - 1

ER -